Now showing items 1-1 of 1
Targeting SARS-CoV2 Spike Protein Receptor Binding Domain by Therapeutic Antibodies
( Elsevier , 2020 , Article)
The Authors As the number of people infected with the newly identified 2019 novel coronavirus (SARS-CoV2) is continuously increasing every day, development of potential therapeutic platforms is vital. Based on the comparatively ...